But Dr. Harlan Krumholz of Yale University says patients may not understand they are still at risk even if they feel good.
US restricts, EU bans controversial diabetes pill →
"Asking a patient, 'Are you doing well on this medication?' isn't an adequate assessment of whether the drug is increasing their risk. It's a silent risk. They don't feel the risk," Krumholz said.